- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Termination of an intrauterine pregnancy
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 372KB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 63KB)
Mifepristone and misoprostol – March 2023
Mifepristone and misoprostol: Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms; MS-2 Step®
Last updated
30 June 2023